What is Precision Labs?
Precision Labs operates as a sophisticated reference laboratory, distinguishing itself through the application of Gold Standard LC MS/MS technology for precise drug detection and medication monitoring. By serving a diverse clinical clientele—ranging from behavioral health facilities and addiction treatment centers to OBGYN and primary care practices—the company bridges the gap between complex analytical chemistry and actionable clinical decision-making. Their business model is predicated on providing not only high-fidelity testing data but also expert consultative support, which is essential for clinicians navigating the complexities of addiction medicine and patient treatment planning. This dual-pronged approach of technical excellence and educational advocacy positions Precision Labs as a critical partner in the modern healthcare ecosystem, particularly in environments where accurate medication adherence monitoring is paramount to patient outcomes.
How much funding has Precision Labs raised?
Precision Labs has raised a total of $367K across 2 funding rounds:
Debt
$150K
Debt
$217K
Debt (2020): $150K with participation from PPP
Debt (2021): $217K led by PPP
Key Investors in Precision Labs
PPP
Public-Private Partnership
What's next for Precision Labs?
With the infusion of $217K, Precision Labs is well-positioned to accelerate its expansion into broader diagnostic markets and enhance its technological footprint. The company's strategic roadmap likely involves scaling its laboratory capacity to meet the rising demand for specialized toxicology services while further integrating its consultative services into digital health workflows. As the firm moves beyond its current growth phase, the focus will likely shift toward optimizing operational efficiencies and deepening its penetration within the addiction treatment and behavioral health verticals. By leveraging its established reputation for precision, the company is poised to influence clinical standards in medication monitoring, potentially exploring new diagnostic modalities that complement its existing LC MS/MS capabilities. The sustained backing from institutional partners provides the necessary liquidity to pursue these long-term objectives while maintaining the rigorous quality standards required in the reference laboratory industry.
See full Precision Labs company page
